Dr. Paul Perco studied Microbiology and Genetics at the University of Vienna and obtained his PhD in 2005 on Network analysis of gene expression data in human kidney disease. After a period as post doctoral fellow at the department of Internal Medicine III at the Medical University of Vienna, he joined the team of emergentec biodevelopment. Until 2016 he was head of applications at emergentec biodevelopment being responsible for the applied bioinformatics projects as well as the development of the e.valuation software platfom. He was for many years lecturer on applied bioinformatics and systems medicine at the Technical University of Vienna in the master program on Medical Informatics. End of 2016 he took on a position as senior researcher at the Medical University of Innsbruck where he successfully completed his habilitation thesis in the field of bioinformatics in 2019 on Network-based bioinformatics disease and drug modeling supporting biomarker and drug target identification.
Dr. Paul Perco has authored over 90 publications in peer-reviewed scientific journals in the area of nephrology, oncology, and bioinformatics methods development. Research focus in recent years was on the characterization of renoprotective mechanisms and factors as well as the identification of prognostic and predictive biomarkers in chronic kidney disease.